
Lymphoma clinical trials
Lymphoma is the most common type of blood cancer.
View lymphoma trials
Clinical Trials
Current clinical trials for blood cancers explore investigational medications including: pembrolizumab, bomedemstat, vibostolimab, nemtabrutinib, zilovertamab vedotin, or favezelimab.
There is a lot to consider when deciding whether to participate in a clinical trial. Any clinical trial includes risks, which the study doctor will review with you. Make sure you understand the risks before participating